Biotechnological research holds great promise for the future, and the U.S. wheat industry recognizes these advancements. In preparation for the future commercialization of biotechnologically-derived wheat, we take the following positions
- We support and will work to ensure the ability of wheat producers to make planting and marketing choices based on economic, agronomic, and market factors.
- We commit ourselves to the principle that our customers’ needs are a very important consideration. We support the ability of our wheat customers to make purchases on the basis of specific traits.
- We support servicing newly emerging market segments for wheat through utilization of market developed and demand driven segregation systems.
- We urge the adoption of a nationally and internationally accepted definition of biotechnologically-derived products. We also urge international harmonization of scientific standards and trade rules.
- We support voluntary labeling of food products, provided it is consistent with U.S. law and international trade agreements and is truthful and not misleading. We oppose government-mandated labeling of wheat products in both the U.S. and international markets based upon the presence or absence of biotechnologically-derived traits that do not differ significantly from their conventional counterpart.
- We support the establishment of a reasonable threshold level for adventitious or accidental inclusion of biotechnologically-derived traits in bulk wheat or wheat food products in both U.S. and international markets.
- We are confident that biotechnology will deliver significant consumer and producer benefits. We support continued biotechnology research, and product and market development. We invite valued and interested customers to join with us in a working partnership to explore the emerging biotechnology industry.
U.S. Wheat Industry Definition: – Biotechnologically Derived (Genetically Modified Organisms) *
Genetically modified organisms (commonly referred to as “transgenic”) are organisms derived from somatic cell fusion or direct insertion of a gene construct, typically but not necessarily from a sexually-incompatible species, using recombinant DNA techniques and any genetic transformation technology (e.g., bacterial vectors, particle bombardment, electroporation).”